Can a psychedelic drug save the terminally ill from their deepest fears of death?


“After one dose of psilocybin, death anxiety declined…nothing in psychology comes close to that!”, psychiatrist Margaret Ross.

St. Vincent’s hospital will undergo novel trials involving psychedelic drugs to help treat depression with 40 palliative care patients. Psilocybin, a psychoactive compound found in magic mushrooms is presenting powerful effects for individuals facing terminal illness.” You can have an experience…where you no longer feel so tethered to suffering and to the body.” This remarkable psychedelic known for its ability to produce mystical experiences shows promising outcomes for individuals coming to terms with imminent death. End-of-life circumstances often cause unimaginable despair, anguish and overwhelming fear.“The depression….often makes it impossible to connect with family, friends, society, memory – self”, psychiatrist Justin Dwyer.

Psilocybin-assisted psychotherapy is part of a revolutionary shift in attitudes towards psychedelic drugs, which are now taking place in many countries around the world.

Click here to read the full article

Image: Kristoffer Paulsen

Share this post

Innovative psychedelic research

The re-emergence of psychedelic research places a crucial emphasis on a holistic approach to mental health from pharmacology, neurobiological process, ecological connection, and therapeutic support.  PRISM supports research and clinical development of therapies where current options provide limited relief.

Your support allows us to pursue cutting edge research for next-generation mental health care.


We are a DGR-1 non-profit research charity developing medical and legal processes for the application of psychedelic medicines for improved wellbeing.


Contact Us

Send us an email and we'll get back to you soon.

Not readable? Change text. captcha txt

Start typing and press Enter to search